SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-012421
Filing Date
2018-05-09
Accepted
2018-05-09 16:16:07
Documents
3
Period of Report
2018-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bold-8k_20180509.htm 8-K 32680
2 EX-99.1 bold-ex991_68.htm EX-99.1 130861
3 GRAPHIC g201805091823288503632.jpg GRAPHIC 5248
  Complete submission text file 0001564590-18-012421.txt   172079
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 18818461
SIC: 2836 Biological Products, (No Diagnostic Substances)